Amniotic fluid epidermal growth factor levels in normal and abnormal pregnancies

Area of Science:

• Reproductive Biology
• Maternal-Fetal Medicine
• Biochemistry

Background:

• Epidermal Growth Factor (EGF) plays a role in fetal development.
• Understanding EGF concentrations in amniotic fluid (AF) during late pregnancy is crucial for assessing fetal well-being.
• Pathophysiologic complications can impact fetal development and amniotic fluid composition.

Purpose of the Study:

• To quantify epidermal growth factor (EGF) levels in amniotic fluid (AF) from women in late pregnancy.
• To investigate the relationship between AF EGF concentrations and various pregnancy complications.

Main Methods:

• Amniotic fluid samples were collected via amniocentesis from diverse patient groups, including those with specific gestational ages and complications.
• Radioimmunoassay was employed to measure epidermal growth factor (EGF) concentrations.
• Study groups included preterm and term pregnancies, chorioamnionitis, intrauterine growth restriction (IUGR), and macrosomia.

Main Results:

• Amniotic fluid EGF levels demonstrated a rapid increase in late pregnancy.
• Chorioamnionitis and labor (term or preterm) did not significantly alter AF EGF levels.
• Intrauterine growth restriction (IUGR) was associated with decreased AF EGF, whereas macrosomia showed no significant effect.

Conclusions:

• Epidermal growth factor (EGF) levels in amniotic fluid (AF) increase near term.
• Decreased AF EGF concentrations may serve as an indicator of intrauterine growth restriction (IUGR).
• EGF levels in AF could potentially reflect specific fetal maturational events.